LSD 1 inhibitors for use in the treatment of type 2 diabetes

Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/243447

COMPARTIR / EXPORTAR:

SHARE BASE	Comparte tu historia de Acceso Abierto
Visualizar otros formatos: MARC \| Dublin Core \| RDF \| ORE \| MODS \| METS \| DIDL \| DATACITE
Refman EndNote Bibtex RefWorks Excel CSV PDF DataCite Send via email

Título:	LSD 1 inhibitors for use in the treatment of type 2 diabetes
Autor:	Gauthier, Benoit R. CSIC ORCID; Lorenzo, Petra Isabel CSIC ORCID; Fuente-Martín, Esther; Cobo-Vuilleumier, Nadia CSIC ORCID; Mellado-Gil, José Manuel CSIC; Bermúdez-Silva, Francisco Javier; Rojo-Martínez, Gemma; Reyes, José C. CSIC ORCID
Fecha de publicación:	30-jul-2020
Citación:	WO2020152280 A1
Resumen:	The present invention is focused on the use of lysine specific demethylase (LSD1) inhibitors for the treatment of type 2 diabetes, by means of the re-differentiation of pancreatic beta cells once they have been de-differentiated.
URI:	http://hdl.handle.net/10261/243447
Aparece en las colecciones:	(CABIMER) Patentes